{"entity":{"type":"insider","cik":"0001706426","url":"/insider/0001706426","json_url":"/insider/0001706426.json","name":"Terrillion Scott","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":19,"n_filings":19,"first":"2019-01-02","last":"2025-03-04","span_basis":"filed_date"},"name_variants":[{"name":"Terrillion Scott","source":"filing","n_filings":19,"first_seen":"2019-01-02","last_seen":"2025-03-04"}],"transactions":[{"id":4074413,"accession":"0001415889-25-006575","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-006575","line_url":"/filing/0001415889-25-006575#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001706426","owner_name":"Terrillion Scott","owner_display_name":"Terrillion Scott","owner_url":"/insider/0001706426","role":"Officer (SEC'Y; CHIEF COMPLIANCE & G.C)","role_mark":"O","role_mark_label":"Officer (SEC'Y; CHIEF COMPLIANCE & G.C)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SEC'Y; CHIEF COMPLIANCE & G.C.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":163.0,"shares_display":"163","price_per_share":4.76,"price_display":"4.76","price_state":"stated","total_value":775.88,"total_display":"775.88","total_whole":"776","shares_owned_after":7190.0,"shares_owned_after_display":"7,190","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-28","filed_date":"2025-03-04","scope":"insider"},{"id":2369604,"accession":"0001415889-24-010569","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-010569","line_url":"/filing/0001415889-24-010569#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001706426","owner_name":"Terrillion Scott","owner_display_name":"Terrillion Scott","owner_url":"/insider/0001706426","role":"Officer (SEC'Y; CHIEF COMPLIANCE & G.C)","role_mark":"O","role_mark_label":"Officer (SEC'Y; CHIEF COMPLIANCE & G.C)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SEC'Y; CHIEF COMPLIANCE & G.C.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2753.0,"shares_display":"2,753","price_per_share":0.83,"price_display":"0.83","price_state":"stated","total_value":2284.99,"total_display":"2,284.99","total_whole":"2,285","shares_owned_after":88247.0,"shares_owned_after_display":"88,247","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-05","filed_date":"2024-04-09","scope":"insider"},{"id":2484190,"accession":"0001415889-24-006282","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-006282","line_url":"/filing/0001415889-24-006282#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001706426","owner_name":"Terrillion Scott","owner_display_name":"Terrillion Scott","owner_url":"/insider/0001706426","role":"Officer (SEC'Y; CHIEF COMPLIANCE & G.C)","role_mark":"O","role_mark_label":"Officer (SEC'Y; CHIEF COMPLIANCE & G.C)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SEC'Y; CHIEF COMPLIANCE & G.C.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3293.0,"shares_display":"3,293","price_per_share":0.89,"price_display":"0.89","price_state":"stated","total_value":2930.77,"total_display":"2,930.77","total_whole":"2,931","shares_owned_after":91000.0,"shares_owned_after_display":"91,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-29","filed_date":"2024-03-04","scope":"insider"},{"id":8022863,"accession":"0001209191-23-039884","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-039884","line_url":"/filing/0001209191-23-039884#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001706426","owner_name":"Terrillion Scott","owner_display_name":"Terrillion Scott","owner_url":"/insider/0001706426","role":"Officer (Sec'y; Chief Compliance & G.C)","role_mark":"O","role_mark_label":"Officer (Sec'y; Chief Compliance & G.C)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sec'y; Chief Compliance & G.C.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2483.0,"shares_display":"2,483","price_per_share":3.51,"price_display":"3.51","price_state":"stated","total_value":8715.33,"total_display":"8,715.33","total_whole":"8,715","shares_owned_after":88563.0,"shares_owned_after_display":"88,563","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-23","filed_date":"2023-06-27","scope":"insider"},{"id":8702594,"accession":"0001209191-23-023607","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-023607","line_url":"/filing/0001209191-23-023607#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001706426","owner_name":"Terrillion Scott","owner_display_name":"Terrillion Scott","owner_url":"/insider/0001706426","role":"Officer (Sec'y; Chief Compliance & G.C)","role_mark":"O","role_mark_label":"Officer (Sec'y; Chief Compliance & G.C)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sec'y; Chief Compliance & G.C.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2481.0,"shares_display":"2,481","price_per_share":4.91,"price_display":"4.91","price_state":"stated","total_value":12181.71,"total_display":"12,181.71","total_whole":"12,182","shares_owned_after":91046.0,"shares_owned_after_display":"91,046","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-04","filed_date":"2023-04-06","scope":"insider"},{"id":8364621,"accession":"0001209191-23-016790","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-016790","line_url":"/filing/0001209191-23-016790#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001706426","owner_name":"Terrillion Scott","owner_display_name":"Terrillion Scott","owner_url":"/insider/0001706426","role":"Officer (Sec'y; Chief Compliance & G.C)","role_mark":"O","role_mark_label":"Officer (Sec'y; Chief Compliance & G.C)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sec'y; Chief Compliance & G.C.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6256.0,"shares_display":"6,256","price_per_share":9.71,"price_display":"9.71","price_state":"stated","total_value":60745.76,"total_display":"60,745.76","total_whole":"60,746","shares_owned_after":93527.0,"shares_owned_after_display":"93,527","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-03","filed_date":"2023-03-07","scope":"insider"},{"id":2390244,"accession":"0001415889-24-003408","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-003408","line_url":"/filing/0001415889-24-003408#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001706426","owner_name":"Terrillion Scott","owner_display_name":"Terrillion Scott","owner_url":"/insider/0001706426","role":"Officer (SEC'Y; CHIEF COMPLIANCE & G.C)","role_mark":"O","role_mark_label":"Officer (SEC'Y; CHIEF COMPLIANCE & G.C)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SEC'Y; CHIEF COMPLIANCE & G.C.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7770.0,"shares_display":"7,770","price_per_share":0.53,"price_display":"0.53","price_state":"stated","total_value":4118.1,"total_display":"4,118.10","total_whole":"4,118","shares_owned_after":94293.0,"shares_owned_after_display":"94,293","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-08","filed_date":"2024-02-12","scope":"insider"},{"id":6107899,"accession":"0001209191-22-062628","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-062628","line_url":"/filing/0001209191-22-062628#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001706426","owner_name":"Terrillion Scott","owner_display_name":"Terrillion Scott","owner_url":"/insider/0001706426","role":"Officer (Sec'y; Chief Compliance & G.C)","role_mark":"O","role_mark_label":"Officer (Sec'y; Chief Compliance & G.C)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sec'y; Chief Compliance & G.C.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2561.0,"shares_display":"2,561","price_per_share":11.27,"price_display":"11.27","price_state":"stated","total_value":28862.47,"total_display":"28,862.47","total_whole":"28,862","shares_owned_after":99783.0,"shares_owned_after_display":"99,783","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-21","filed_date":"2022-12-23","scope":"insider"},{"id":6273119,"accession":"0001209191-22-023249","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-023249","line_url":"/filing/0001209191-22-023249#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001706426","owner_name":"Terrillion Scott","owner_display_name":"Terrillion Scott","owner_url":"/insider/0001706426","role":"Officer (Sec'y; Chief Compliance & G.C)","role_mark":"O","role_mark_label":"Officer (Sec'y; Chief Compliance & G.C)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sec'y; Chief Compliance & G.C.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1642.0,"shares_display":"1,642","price_per_share":11.91,"price_display":"11.91","price_state":"stated","total_value":19556.22,"total_display":"19,556.22","total_whole":"19,556","shares_owned_after":102344.0,"shares_owned_after_display":"102,344","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-01","filed_date":"2022-04-05","scope":"insider"},{"id":6890418,"accession":"0001209191-22-016431","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-016431","line_url":"/filing/0001209191-22-016431#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001706426","owner_name":"Terrillion Scott","owner_display_name":"Terrillion Scott","owner_url":"/insider/0001706426","role":"Officer (Sec'y; Chief Compliance & G.C)","role_mark":"O","role_mark_label":"Officer (Sec'y; Chief Compliance & G.C)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sec'y; Chief Compliance & G.C.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1787.0,"shares_display":"1,787","price_per_share":11.38,"price_display":"11.38","price_state":"stated","total_value":20336.06,"total_display":"20,336.06","total_whole":"20,336","shares_owned_after":103986.0,"shares_owned_after_display":"103,986","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-03","filed_date":"2022-03-04","scope":"insider"},{"id":6890153,"accession":"0001209191-22-013994","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-013994","line_url":"/filing/0001209191-22-013994#line-2","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001706426","owner_name":"Terrillion Scott","owner_display_name":"Terrillion Scott","owner_url":"/insider/0001706426","role":"Officer (Sec'y; Chief Compliance & G.C)","role_mark":"O","role_mark_label":"Officer (Sec'y; Chief Compliance & G.C)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sec'y; Chief Compliance & G.C.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1972.0,"shares_display":"1,972","price_per_share":10.29,"price_display":"10.29","price_state":"stated","total_value":20291.88,"total_display":"20,291.88","total_whole":"20,292","shares_owned_after":100440.0,"shares_owned_after_display":"100,440","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-25","filed_date":"2022-03-01","scope":"insider"},{"id":5430062,"accession":"0001209191-21-054304","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-054304","line_url":"/filing/0001209191-21-054304#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001706426","owner_name":"Terrillion Scott","owner_display_name":"Terrillion Scott","owner_url":"/insider/0001706426","role":"Officer (Sec'y; Chief Compliance & G.C)","role_mark":"O","role_mark_label":"Officer (Sec'y; Chief Compliance & G.C)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sec'y; Chief Compliance & G.C.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1759.0,"shares_display":"1,759","price_per_share":14.2,"price_display":"14.20","price_state":"stated","total_value":24977.8,"total_display":"24,977.80","total_whole":"24,978","shares_owned_after":70917.0,"shares_owned_after_display":"70,917","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-30","filed_date":"2021-09-01","scope":"insider"},{"id":4717830,"accession":"0001209191-21-018652","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-018652","line_url":"/filing/0001209191-21-018652#line-2","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001706426","owner_name":"Terrillion Scott","owner_display_name":"Terrillion Scott","owner_url":"/insider/0001706426","role":"Officer (Sec'y; Chief Compliance & G.C)","role_mark":"O","role_mark_label":"Officer (Sec'y; Chief Compliance & G.C)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sec'y; Chief Compliance & G.C.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3090.0,"shares_display":"3,090","price_per_share":17.98,"price_display":"17.98","price_state":"stated","total_value":55558.2,"total_display":"55,558.20","total_whole":"55,558","shares_owned_after":51342.0,"shares_owned_after_display":"51,342","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-05","filed_date":"2021-03-08","scope":"insider"},{"id":4774268,"accession":"0001209191-21-014551","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-014551","line_url":"/filing/0001209191-21-014551#line-2","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001706426","owner_name":"Terrillion Scott","owner_display_name":"Terrillion Scott","owner_url":"/insider/0001706426","role":"Officer (Sec'y; Chief Compliance & G.C)","role_mark":"O","role_mark_label":"Officer (Sec'y; Chief Compliance & G.C)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sec'y; Chief Compliance & G.C.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4004.0,"shares_display":"4,004","price_per_share":19.33,"price_display":"19.33","price_state":"stated","total_value":77397.32,"total_display":"77,397.32","total_whole":"77,397","shares_owned_after":44432.0,"shares_owned_after_display":"44,432","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-25","filed_date":"2021-02-25","scope":"insider"},{"id":3020157,"accession":"0001209191-20-065582","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-065582","line_url":"/filing/0001209191-20-065582#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001706426","owner_name":"Terrillion Scott","owner_display_name":"Terrillion Scott","owner_url":"/insider/0001706426","role":"Officer (Sec'y; Chief Compliance & G.C)","role_mark":"O","role_mark_label":"Officer (Sec'y; Chief Compliance & G.C)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sec'y; Chief Compliance & G.C.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1946.0,"shares_display":"1,946","price_per_share":15.3,"price_display":"15.30","price_state":"stated","total_value":29773.8,"total_display":"29,773.80","total_whole":"29,774","shares_owned_after":42436.0,"shares_owned_after_display":"42,436","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-30","filed_date":"2020-12-30","scope":"insider"},{"id":2468867,"accession":"0001209191-20-025308","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-025308","line_url":"/filing/0001209191-20-025308#line-2","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001706426","owner_name":"Terrillion Scott","owner_display_name":"Terrillion Scott","owner_url":"/insider/0001706426","role":"Officer (Sec'y; Chief Compliance & G.C)","role_mark":"O","role_mark_label":"Officer (Sec'y; Chief Compliance & G.C)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sec'y; Chief Compliance & G.C.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2721.0,"shares_display":"2,721","price_per_share":15.56,"price_display":"15.56","price_state":"stated","total_value":42338.76,"total_display":"42,338.76","total_whole":"42,339","shares_owned_after":38382.0,"shares_owned_after_display":"38,382","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-21","filed_date":"2020-04-21","scope":"insider"},{"id":8011266,"accession":"0001209191-19-059185","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-059185","line_url":"/filing/0001209191-19-059185#line-2","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001706426","owner_name":"Terrillion Scott","owner_display_name":"Terrillion Scott","owner_url":"/insider/0001706426","role":"Officer (Sec'y; Chief Compliance & G.C)","role_mark":"O","role_mark_label":"Officer (Sec'y; Chief Compliance & G.C)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sec'y; Chief Compliance & G.C.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3980.0,"shares_display":"3,980","price_per_share":17.05,"price_display":"17.05","price_state":"stated","total_value":67859.0,"total_display":"67,859.00","total_whole":"67,859","shares_owned_after":16769.0,"shares_owned_after_display":"16,769","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-04","filed_date":"2019-12-04","scope":"insider"},{"id":8239049,"accession":"0001209191-19-033519","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-033519","line_url":"/filing/0001209191-19-033519#line-2","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001706426","owner_name":"Terrillion Scott","owner_display_name":"Terrillion Scott","owner_url":"/insider/0001706426","role":"Officer (Sec'y; Chief Compliance & G.C)","role_mark":"O","role_mark_label":"Officer (Sec'y; Chief Compliance & G.C)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sec'y; Chief Compliance & G.C.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2303.0,"shares_display":"2,303","price_per_share":21.38,"price_display":"21.38","price_state":"stated","total_value":49238.14,"total_display":"49,238.14","total_whole":"49,238","shares_owned_after":12416.0,"shares_owned_after_display":"12,416","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-29","filed_date":"2019-05-30","scope":"insider"},{"id":8388182,"accession":"0001209191-19-000405","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-000405","line_url":"/filing/0001209191-19-000405#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001706426","owner_name":"Terrillion Scott","owner_display_name":"Terrillion Scott","owner_url":"/insider/0001706426","role":"Officer (Sec'y; Chief Compliance & G.C)","role_mark":"O","role_mark_label":"Officer (Sec'y; Chief Compliance & G.C)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sec'y; Chief Compliance & G.C.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3100.0,"shares_display":"3,100","price_per_share":12.51,"price_display":"12.51","price_state":"stated","total_value":38781.0,"total_display":"38,781.00","total_whole":"38,781","shares_owned_after":6386.0,"shares_owned_after_display":"6,386","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-28","filed_date":"2019-01-02","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":19,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":19,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":19},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001346830","name":"Cara Therapeutics, Inc.","url":"/issuer/0001346830","role":"Officer (SEC'Y; CHIEF COMPLIANCE & G.C)","n_filings":19,"first_seen":"2019-01-02","last_seen":"2025-03-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001706426","retrieved_at":"2026-08-23T21:45:11+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}